Seattle, Washington – Lead singer of the iconic rock band Heart, Ann Wilson, revealed that she has been diagnosed with cancer and is currently undergoing preventive chemotherapy. As a result, the band has made the decision to postpone their tour.
In a statement released on July 2, Wilson shared that she had recently undergone a successful operation to remove a cancerous growth. Despite feeling great post-surgery, her doctors have recommended a course of preventive chemotherapy, leading to the postponement of all remaining dates on the North American leg of the band’s “Royal Flush Tour.”
Preventive chemotherapy is a treatment aimed at reducing the risk of cancer recurrence after initial treatment. Wilson, 74, expressed her commitment to returning to the stage in 2025, reassuring fans that this pause is temporary.
Although she did not disclose the specific type of cancer she is battling, Wilson urged ticket holders to hold onto their tickets as they would be honored on rescheduled dates in the future. This announcement comes after the band had to cancel the European leg of their tour earlier due to a medical procedure Wilson underwent.
Heart, which comprises Wilson and her sister Nancy Wilson, had kicked off their latest tour in the United States in April. The band’s scheduled performances in Europe this summer have been put on hold as they prioritize Wilson’s health and recovery.
Fans have been supportive of Wilson, sending her well-wishes during this challenging time. Wilson’s commitment to returning to the stage in the future remains unwavering, emphasizing that she has more music to share with her audience.